Andrew J. Schwab - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of 5:01 Acquisition Corp (FVAM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of 5:01 Acquisition Corp (FVAM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

5:01 Acquisition Corp (FVAM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Andrew J. Schwab made no insider transaction in Aprea Therapeutics Inc (APRE). Other recent insider transactions involving Aprea Therapeutics Inc (APRE) include a net purchase of 33,600 shares made by Oren Gilad , a net purchase of 10,700 shares made by John P. Hamill , and a net purchase of 21,459 shares made by Marc Duey .

In summary, during the past 3 months, insiders sold 0 shares of Aprea Therapeutics Inc (APRE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aprea Therapeutics Inc (APRE) were sold and 65,759 shares were bought by its insiders, resulting in a net purchase of 65,759 shares.

Aprea Therapeutics Inc (APRE)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Akouos Inc (AKUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akouos Inc (AKUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Akouos Inc (AKUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of scPharmaceuticals Inc (SCPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of scPharmaceuticals Inc (SCPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

scPharmaceuticals Inc (SCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Andrew J. Schwab made no insider transaction in Cabaletta Bio Inc (CABA). Other recent insider transactions involving Cabaletta Bio Inc (CABA) include a net purchase of 45,000 shares made by Steven Nichtberger , a net purchase of 22,725 shares made by Shawn Tomasello , and a net purchase of 22,170 shares made by Steve Gavel .

In summary, during the past 3 months, insiders sold 0 shares of Cabaletta Bio Inc (CABA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cabaletta Bio Inc (CABA) were sold and 132,073 shares were bought by its insiders, resulting in a net purchase of 132,073 shares.

Cabaletta Bio Inc (CABA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Andrew J. Schwab made no insider transaction in Arvinas Inc (ARVN). Other recent insider transactions involving Arvinas Inc (ARVN) include a net sale of 23,017 shares made by Angela M Cacace , a net sale of 31,886 shares made by Noah Berkowitz , and a net sale of 27,669 shares made by Andrew Saik .

In summary, during the past 3 months, insiders sold 8,272 shares of Arvinas Inc (ARVN) in total and bought 0 shares, with a net sale of 8,272 shares. During the past 18 months, 143,197 shares of Arvinas Inc (ARVN) were sold and 50,000 shares were bought by its insiders, resulting in a net sale of 93,197 shares.

Arvinas Inc (ARVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Andrew J. Schwab made no insider transaction in Crinetics Pharmaceuticals Inc (CRNX). Other recent insider transactions involving Crinetics Pharmaceuticals Inc (CRNX) include a net sale of 59,007 shares made by Dana Pizzuti , a net sale of 113,865 shares made by Stephen F. Betz , and a net sale of 102,236 shares made by Jeff E. Knight .

In summary, during the past 3 months, insiders sold 9,900 shares of Crinetics Pharmaceuticals Inc (CRNX) in total and bought 0 shares, with a net sale of 9,900 shares. During the past 18 months, 361,540 shares of Crinetics Pharmaceuticals Inc (CRNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 361,540 shares.

Crinetics Pharmaceuticals Inc (CRNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Andrew J. Schwab made no insider transaction in IDEAYA Biosciences Inc (IDYA). Other recent insider transactions involving IDEAYA Biosciences Inc (IDYA) include a net purchase of 50,000 shares made by Jeffrey Stein , and a net sale of 9,550 shares made by Briseno Andres Ruiz .

In summary, during the past 3 months, insiders sold 9,550 shares of IDEAYA Biosciences Inc (IDYA) in total and bought 0 shares, with a net sale of 9,550 shares. During the past 18 months, 9,550 shares of IDEAYA Biosciences Inc (IDYA) were sold and 50,000 shares were bought by its insiders, resulting in a net purchase of 40,450 shares.

IDEAYA Biosciences Inc (IDYA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Homology Medicines Inc (FIXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Homology Medicines Inc (FIXX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Homology Medicines Inc (FIXX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Audentes Therapeutics Inc (BOLD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Audentes Therapeutics Inc (BOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Audentes Therapeutics Inc (BOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of PhaseRx Inc (PZRXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PhaseRx Inc (PZRXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

PhaseRx Inc (PZRXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Viveve Medical Inc (VIVE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Viveve Medical Inc (VIVE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Viveve Medical Inc (VIVE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Andrew J. Schwab made no insider transaction in Cidara Therapeutics Inc (CDTX). Other recent insider transactions involving Cidara Therapeutics Inc (CDTX) include a net sale of 11,623 shares made by Shane Ward , a net purchase of 2,272,727 shares made by Ra Capital Healthcare Fund Lp , and a net purchase of 3,320 shares made by Chrysa Mineo .

In summary, during the past 3 months, insiders sold 0 shares of Cidara Therapeutics Inc (CDTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 13,870 shares of Cidara Therapeutics Inc (CDTX) were sold and 2,276,047 shares were bought by its insiders, resulting in a net purchase of 2,262,177 shares.

Cidara Therapeutics Inc (CDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of EPIRUS Biopharmaceuticals Inc (EPRSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of EPIRUS Biopharmaceuticals Inc (EPRSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

EPIRUS Biopharmaceuticals Inc (EPRSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Flexion Therapeutics Inc (FLXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Flexion Therapeutics Inc (FLXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Flexion Therapeutics Inc (FLXN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of IPI Legacy Liquidation Co (IMPLQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of IPI Legacy Liquidation Co (IMPLQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

IPI Legacy Liquidation Co (IMPLQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Andrew J. Schwab made no insider transaction in Entrada Therapeutics Inc (TRDA). Other recent insider transactions involving Entrada Therapeutics Inc (TRDA) include a net sale of 623,729 shares made by Kush Parmar , a net sale of 531,285 shares made by 5am Ventures V, L.p. , and a net sale of 37,659 shares made by Kory James Wentworth .

In summary, during the past 3 months, insiders sold 750,270 shares of Entrada Therapeutics Inc (TRDA) in total and bought 0 shares, with a net sale of 750,270 shares. During the past 18 months, 1,547,846 shares of Entrada Therapeutics Inc (TRDA) were sold and 211,911 shares were bought by its insiders, resulting in a net sale of 1,335,935 shares.

Entrada Therapeutics Inc (TRDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Andrew J. Schwab made no insider transaction in Rallybio Corp (RLYB). Other recent insider transactions involving Rallybio Corp (RLYB) include a net purchase of 302,473 shares made by Adar1 Capital Management, Llc , and a net sale of 789 shares made by Jonathan I Lieber .

In summary, during the past 3 months, insiders sold 0 shares of Rallybio Corp (RLYB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 789 shares of Rallybio Corp (RLYB) were sold and 302,473 shares were bought by its insiders, resulting in a net purchase of 301,684 shares.

Rallybio Corp (RLYB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Andrew J. Schwab made no insider transaction in Vor Biopharma Inc (VOR). Other recent insider transactions involving Vor Biopharma Inc (VOR) include a net sale of 6,665,043 shares made by Reprogrammed Interchange Llc , and a net sale of 4,205,765 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 213 shares of Vor Biopharma Inc (VOR) in total and bought 0 shares, with a net sale of 213 shares. During the past 18 months, 4,987,561 shares of Vor Biopharma Inc (VOR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,987,561 shares.

Vor Biopharma Inc (VOR)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Pear Therapeutics Inc (PEARQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pear Therapeutics Inc (PEARQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Pear Therapeutics Inc (PEARQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of CinCor Pharma Inc (CINC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CinCor Pharma Inc (CINC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CinCor Pharma Inc (CINC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Andrew J. Schwab made no insider transaction in Enliven Therapeutics Inc (ELVN). Other recent insider transactions involving Enliven Therapeutics Inc (ELVN) include a net sale of 275,000 shares made by Joseph P Lyssikatos , a net sale of 112,500 shares made by Samuel Kintz , and a net sale of 55,804 shares made by Benjamin Hohl .

In summary, during the past 3 months, insiders sold 1,353,380 shares of Enliven Therapeutics Inc (ELVN) in total and bought 0 shares, with a net sale of 1,353,380 shares. During the past 18 months, 2,049,976 shares of Enliven Therapeutics Inc (ELVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,049,976 shares.

Enliven Therapeutics Inc (ELVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Andrew J. Schwab made 2 insider transaction in Skye Bioscience Inc (SKYE) with a net sale of 607,245. Other recent insider transactions involving Skye Bioscience Inc (SKYE) include a net sale of 607,245 shares made by 5am Partners Vii, Llc ,

In summary, during the past 3 months, insiders sold 93,960 shares of Skye Bioscience Inc (SKYE) in total and bought 0 shares, with a net sale of 93,960 shares. During the past 18 months, 151,811 shares of Skye Bioscience Inc (SKYE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 151,811 shares.

Skye Bioscience Inc (SKYE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Andrew J. Schwab made no insider transaction in Q32 Bio Inc (QTTB). Other recent insider transactions involving Q32 Bio Inc (QTTB) include a net sale of 52,741 shares made by Jodie Pope Morrison , a net sale of 21,279 shares made by Lee Kalowski , and a net sale of 8,603 shares made by Shelia M. Violette .

In summary, during the past 3 months, insiders sold 16,615 shares of Q32 Bio Inc (QTTB) in total and bought 0 shares, with a net sale of 16,615 shares. During the past 18 months, 82,623 shares of Q32 Bio Inc (QTTB) were sold and 3,750,000 shares were bought by its insiders, resulting in a net purchase of 3,667,377 shares.

Q32 Bio Inc (QTTB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Andrew J. Schwab made 3 insider transaction in Camp4 Therapeutics Corp (CAMP) with a net sale of 591,875. Other recent insider transactions involving Camp4 Therapeutics Corp (CAMP) include a net purchase of 31,529 shares made by Richard A Young , a net purchase of 12,611 shares made by Yuri Maricich , and a net purchase of 12,611 shares made by Josh Mandel-brehm .

In summary, during the past 3 months, insiders sold 593,613 shares of Camp4 Therapeutics Corp (CAMP) in total and bought 36,031 shares, with a net sale of 557,582 shares. During the past 18 months, 593,613 shares of Camp4 Therapeutics Corp (CAMP) were sold and 5,624,916 shares were bought by its insiders, resulting in a net purchase of 5,031,303 shares.

Camp4 Therapeutics Corp (CAMP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Andrew J. Schwab made no insider transaction in Artiva Biotherapeutics Inc (ARTV). Other recent insider transactions involving Artiva Biotherapeutics Inc (ARTV) include a net purchase of 8,636,021 shares made by Ra Capital Healthcare Fund Lp , a net sale of 87,678 shares made by Fred Aslan , and a net sale of 15,688 shares made by Subhashis Banerjee .

In summary, during the past 3 months, insiders sold 8,651 shares of Artiva Biotherapeutics Inc (ARTV) in total and bought 2,125,605 shares, with a net purchase of 2,116,954 shares. During the past 18 months, 122,253 shares of Artiva Biotherapeutics Inc (ARTV) were sold and 10,068,312 shares were bought by its insiders, resulting in a net purchase of 9,946,059 shares.

Artiva Biotherapeutics Inc (ARTV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Andrew J. Schwab made no insider transaction in Latigo Biotherapeutics Inc (LTGO). Other recent insider transactions involving Latigo Biotherapeutics Inc (LTGO) include a net purchase of 140,000 shares made by Foresite Capital Fund V, L.p. , and a net purchase of 140,000 shares made by James B. Tananbaum .

In summary, during the past 3 months, insiders sold 0 shares of Latigo Biotherapeutics Inc (LTGO) in total and bought 280,000 shares, with a net purchase of 280,000 shares. During the past 18 months, 0 shares of Latigo Biotherapeutics Inc (LTGO) were sold and 280,000 shares were bought by its insiders, resulting in a net purchase of 280,000 shares.

Latigo Biotherapeutics Inc (LTGO)'s detailed insider trading history can be found in Insider Trading Tracker table.